FMBTD
ITCI

First Midwest Bank Trust Division’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

First Midwest Bank Trust Division’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$3.99M Sell
76,281
-20,077
-21% -$843K 0.51% 41
2021
Q3 		$3.59M Buy
96,358
+15,327
+19% +$533K 0.51% 46
2021
Q2 		$3.31M Sell
81,031
-11,473
-12% -$424K 0.45% 57
2021
Q1 		$3.14M Sell
92,504
-42,387
-31% -$1.47M 0.43% 57
2020
Q4 		$4.29M Sell
134,891
-95,312
-41% -$2.5M 0.62% 40
2020
Q3 		$5.91M Sell
230,203
-40,016
-15% -$913K 0.92% 19
2020
Q2 		$6.94M Buy
270,219
+95,625
+55% +$1.94M 1.13% 10
2020
Q1 		$2.68M Buy
174,594
+72,705
+71% +$1.58M 0.49% 45
2019
Q4 		$3.5M Buy
+101,889
New +$1.22M 0.47% 47
2019
Q3 		– Sell
-600,236
Closed -$7.79M – 377
2019
Q2 		$7.79M Buy
600,236
+246,644
+70% +$3.16M 1.11% 11
2019
Q1 		$4.31M Buy
353,592
+26,366
+8% +$337K 0.59% 42
2018
Q4 		$3.73M Buy
327,226
+122,756
+60% +$1.98M 0.56% 42
2018
Q3 		$4.44M Buy
204,470
+25,880
+14% +$541K 0.6% 37
2018
Q2 		$3.16M Buy
178,590
+72,408
+68% +$1.47M 0.45% 52
2018
Q1 		$2.23M Sell
106,182
-80,938
-43% -$1.58M 0.31% 97
2017
Q4 		$2.71M Buy
187,120
+2,284
+1% +$35.3K 0.34% 76
2017
Q3 		$2.92M Buy
184,836
+28,487
+18% +$418K 0.36% 77
2017
Q2 		$1.94M Buy
156,349
+54,023
+53% +$626K 0.24% 112
2017
Q1 		$1.66M Buy
+102,326
New +$1.48M 0.2% 144

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

First Midwest Bank Trust Division's ITCI Position: Q4 2021 in Review

First Midwest Bank Trust Division reduced its Intra-Cellular Therapies Inc. (ITCI) stake by 21% in Q4 2021, selling an estimated $843K and leaving 76,281 shares worth $3.99M. The position accounts for 0.51% of the portfolio, ranked #41.

First Midwest Bank Trust Division first reported a position in ITCI in Q1 2017 and has held it in 19 quarters since. The position peaked at $7.79M in Q2 2019. 208 funds tracked by Wall St. Rank hold ITCI as of Q4 2021.

  • First Midwest Bank Trust Division held 76,281 shares of Intra-Cellular Therapies Inc. worth $3.99M as of Q4 2021.
  • First Midwest Bank Trust Division sold 20,077 Intra-Cellular Therapies Inc. shares in Q4 2021, an estimated $843K.
  • Intra-Cellular Therapies Inc. made up 0.51% of First Midwest Bank Trust Division's portfolio in Q4 2021, its #41 holding.
  • First Midwest Bank Trust Division first reported a position in Intra-Cellular Therapies Inc. in Q1 2017 and has held it in 19 quarters since.
  • First Midwest Bank Trust Division's Intra-Cellular Therapies Inc. position peaked at $7.79M in Q2 2019.
  • 208 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q4 2021.

Based on First Midwest Bank Trust Division's 13F filing for Q4 2021, filed 18 Jan 2022.